ConductScience.org, home

Paper10072079

The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.

Lin X and 4 others. Immunity, 1999. Cited by 166 papers, by iCite.

Cite this record

ConductScience Library. The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases. Papers, record 10072079. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10072079

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.
PubMed
Journal
Immunity
PubMed
Year
1999
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
166
iCite
Relative citation ratio, by iCite
2.51
iCite
Revised in PubMed
2026-01-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lin XX
2Cunningham ET JrE T
3Mu YY
4Geleziunas RR
5Greene WCW C

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CD28 AntigensMajor topic
CD3 ComplexMajor topic
MAP Kinase Kinase KinasesMajor topic
NF-kappa BMajor topic
Protein Serine-Threonine KinasesMajor topic
Proto-Oncogene ProteinsMajor topic
Enzyme Induction
Humans
I-kappa B Kinase
Jurkat Cells
Proto-Oncogene Mas
Transcription Factor AP-1
Transcription, Genetic
NF-kappaB-Inducing Kinase

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
K08-EY00352NEI NIH HHSUnited StatesK08EY000352PubMed and NIHNIH RePORTER
P30A127763PHS HHSUnited StatesPubMedPubMed

Download CSV of grants

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 166 citations.

PMIDTitleJournalYearIn PapersSource
30482227Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/30482227PubMed
28361341Cot kinase plays a critical role in Helicobacter pylori-induced IL-8 expression.J Microbiol2017https://conductscience.org/library/papers/28361341PubMed
27695399NF-κB Pathways in the Pathogenesis of Multiple Sclerosis and the Therapeutic Implications.Front Mol Neurosci2016https://conductscience.org/library/papers/27695399PubMed
27508514Emerging Roles for Noncanonical NF-κB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.Inflamm Bowel Dis2016https://conductscience.org/library/papers/27508514PubMed
26269411Loss of NDRG2 enhanced activation of the NF-κB pathway by PTEN and NIK phosphorylation for ATL and other cancer development.Sci Rep2015https://conductscience.org/library/papers/26269411PubMed
25723737Tumor progression locus 2 (Tpl2) kinase as a novel therapeutic target for cancer: double-sided effects of Tpl2 on cancer.Int J Mol Sci2015https://conductscience.org/library/papers/25723737PubMed
25674762Aberrant expression of COT is related to recurrence of papillary thyroid cancer.Medicine (Baltimore)2015https://conductscience.org/library/papers/25674762PubMed
25531326Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.Oncogene2015https://conductscience.org/library/papers/25531326PubMed
25316791Intestinal myofibroblast-specific Tpl2-Cox-2-PGE2 pathway links innate sensing to epithelial homeostasis.Proc Natl Acad Sci U S A2014https://conductscience.org/library/papers/25316791PubMed
24996903A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.Retrovirology2014https://conductscience.org/library/papers/24996903PubMed
24488495RelB-induced expression of Cot, an MAP3K family member, rescues RANKL-induced osteoclastogenesis in alymphoplasia mice by promoting NF-κB2 processing by IKKα.J Biol Chem2014https://conductscience.org/library/papers/24488495PubMed
22988300IκB kinase 2 regulates TPL-2 activation of extracellular signal-regulated kinases 1 and 2 by direct phosphorylation of TPL-2 serine 400.Mol Cell Biol2012https://conductscience.org/library/papers/22988300PubMed
22615493Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein.Mol Cell Biol2012https://conductscience.org/library/papers/22615493PubMed
21135874Regulation and function of TPL-2, an IκB kinase-regulated MAP kinase kinase kinase.Cell Res2011https://conductscience.org/library/papers/21135874PubMed
20930110
A novel pentamethoxyflavone down-regulates tumor cell survival and proliferative and angiogenic gene products through inhibition of IκB kinase activation and sensitizes tumor cells to apoptosis by cytokines and chemotherapeutic agents.
Mol Pharmacol2011https://conductscience.org/library/papers/20930110PubMed
20685151NF-κB inducing kinase: a key regulator in the immune system and in cancer.Cytokine Growth Factor Rev2010https://conductscience.org/library/papers/20685151PubMed
20534709An enigmatic tail of CD28 signaling.Cold Spring Harb Perspect Biol2010https://conductscience.org/library/papers/20534709PubMed
20368329Combinatorial signals from CD28 differentially regulate human immunodeficiency virus transcription in T cells.J Biol Chem2010https://conductscience.org/library/papers/20368329PubMed
19649278Comparison of peptide array substrate phosphorylation of c-Raf and mitogen activated protein kinase kinase kinase 8.PLoS One2009https://conductscience.org/library/papers/19649278PubMed
18831712BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes.Biochem J2009https://conductscience.org/library/papers/18831712PubMed

See all 53 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10072079

GET https://conductscience.org/api/papers/v1/10072079/cited_by?page=2